CIK: 1874482 - Address: C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD 20850
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/6/23 16:15
12/4/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-6395.140-124-27333D
12/1/23 17:14
11/29/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-1285.000-26-7333D
7/12/23 18:06
7/10/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-1515.030-30-8333D
6/15/23 16:30
6/13/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-2215.040-44-12333D
5/5/23 17:09
5/3/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.d-815.020-16-5333D
4/12/23 16:37
4/10/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-755.000-15-4333D
4/7/23 16:42
4/5/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-1755.020-35-9333D
4/4/23 18:59
3/31/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-515.020-10-3333D
2/3/23 16:31
2/1/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-1725.720-30-8333D
1/5/23 17:39
1/3/23
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiDoerfler DouglasMDDOP,CEOS.dm-1525.080-30-8333D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact